Share & more
The USA's largest AIDS organisation, AIDS Healthcare Foundation (AHF), has praised the World Health Organisation (WHO) for delisting three generic anti-AIDS drugs by Indian manufacturer Ranbaxy.
AHF, which also operates in Africa and Central America, warned that WHO's decision to remove the drugs from its pre-qualification list of anti-AIDS treatments should not be seen as a threat to the validity and efficacy of generic antiretroviral drugs as a whole.
"At a time when the Bush administration is forbidding the use of generic drugs in the developing world, depriving millions access to life-saving drugs, it is good to see that the WHO is looking out for the interests of poor people living with HIV and AIDS," AHF president Michael Weinstein said in a statement.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions